Skip to search.
 TSX Up 1.59% TSX Ventures Down 0.37%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
33.78 Down 0.83(2.40%) Jul 29, 4:00PM EDT
Add to Portfolio
Prev Close:34.61
Open:34.66
Bid:0.01 x 100
Ask:38.84 x 100
1y Target Est:45.50
Beta:0.92
Next Earnings Date:30-Jul-15ACOR Earnings announcement
Day's Range:33.38 - 34.97
52wk Range:28.26 - 45.45
Volume:494,830
Avg Vol (3m):576,406
Market Cap:1.45B
P/E (ttm):102.05
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORDown 2.40%1.45B
BIIBDown 2.06%73.69B
TEVADown 0.74%60.11B

Key Statistics

Forward P/E (1 yr):36.32
P/S (ttm):3.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.58
Quarterly EPS Est (Jun-15) :0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback